<--- Back to Details
First PageDocument Content
Pharmaceutical sciences / Center for Biologics Evaluation and Research / Form FDA 483 / Good manufacturing practice / Biologic / Quality management system / Office of Regulatory Affairs / Title 21 of the Code of Federal Regulations / Limulus amebocyte lysate / Food and Drug Administration / Medicine / Health
Pharmaceutical sciences
Center for Biologics Evaluation and Research
Form FDA 483
Good manufacturing practice
Biologic
Quality management system
Office of Regulatory Affairs
Title 21 of the Code of Federal Regulations
Limulus amebocyte lysate
Food and Drug Administration
Medicine
Health

Compliance Program Guidance Manual

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 288,57 KB

Share Document on Facebook

Similar Documents

Federal Register / Vol. 83, NoWednesday, May 2, Notices Dated: April 27, 2018. William N. Parham, III, Director, Paperwork Reduction Staff, Office of Strategic Operations and Regulatory Affairs.

DocID: 1vaNR - View Document

May 18, 2017 ATTN: Desk Officer, Department of State Office of Information and Regulatory Affairs Office of Management and Budget Eisenhower Executive Office Building 1650 Pennsylvania Avenue, NW

DocID: 1uCn4 - View Document

February 7, 2017 Mr. Dominic Mancini Acting Administrator Office of Information and Regulatory Affairs Office of Management and Budget Eisenhower Executive Office Building

DocID: 1urMY - View Document

Regulatory Affairs In the College of Sciences OFFICE: Geology/Mathematics/Computer Science 619 TELEPHONE: FAX: E-MAIL:

DocID: 1tO7A - View Document

HUD-Administered Manufactured Home Installation Program Program Information and Documents Office of Manufactured Housing Programs Office of Risk Management and Regulatory Affairs

DocID: 1tnpY - View Document